Expression of the MEN-1 gene in a large kindred with multiple endocrine neoplasia type 1

Journal of Internal Medicine

Volumn 243, Issue 6, 1998, Pages 465-470

  Burgess, J R ^a   Greenaway, T M ^a   Shepherd, J J ^b  

^a ROYAL HOBART HOSPITAL   (Australia)

^b UNIVERSITY OF TASMANIA   (Australia)

Author keywords

Adrenal; Enteropancreatic; Hyperparathyroidism; MEN 1; Pituitary; Screening

Indexed keywords

ADRENAL CORTEX ADENOMA; ADULT; AGED; CANCER MORTALITY; CARCINOID; CONFERENCE PAPER; FAMILIAL CANCER; GASTRINOMA; HUMAN; HYPERPARATHYROIDISM; HYPOPHYSIS TUMOR; INSULINOMA; MAJOR CLINICAL STUDY; METASTASIS; MULTIPLE ENDOCRINE NEOPLASIA; PANCREAS ADENOMA; PARATHYROIDECTOMY; PRIORITY JOURNAL; PROLACTINOMA;

ADRENAL CORTEX; ADRENAL GLAND NEOPLASMS; ADULT; AGE FACTORS; CARCINOID TUMOR; DIGESTIVE SYSTEM NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPERPARATHYROIDISM; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; PITUITARY NEOPLASMS; PROGNOSIS;

EID: 0031862349     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.1998.00275.x     Document Type: Conference Paper

References (22)

1. Wermer P. Genetic aspects of adenomatosis of endocrine glands. Am J Med 1954; 116: 363-71.
2. Ballard HS, Frame B, Hartsock RJ. Familial multiple endocrine adenoma-peptic ulcer complex. Medicine 1964; 43: 481-516.
3. Skogseid B, Rastad J, Oberg K. Multiple endocrine neoplasia type I - clinical features and screening. Endocrinol Metab Clin North Am 1994; 1: 1-1-8.
4. Marx SJ, Vinik AI Santen RJ et al. Multiple endocrine neoplasia type 1 : assessment of laboratory tests to screen for the gene in a large kindred. Medicine 1986; 65: 226-41.
5. Chandrasekharappa SC, Guru SC, Manickam P et al. 1997 Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 1997; 276: 404-7.
6. Shepherd JJ, Challis DR, Davies PF et al. Multiple endocrine neoplasia. type 1. Gastrinomas, pancreatic neoplasms, microcarcinoids, the Zollinger-Ellison syndrome, lymph nodes, and hepatic metastases. Arch Surg 1993; 128: 1133-42.
7. Shepherd JJ. The natural history of multiple endocrine neoplasia type 1: highly uncommon or highly unrecognised? Arch Surg 1991; 126: 935-52.
8. Burgess JR, Harle RA, Tucker P et al. Adrenal lesions in a large kindred with multiple endocrine neoplasia type 1. Arch Surg 1998; 131: 699-702.
9. Teh BT, McArdle JP, Chan SP et al. Clinicopathological studies of thymic carcinoids in multiple endocrine neoplasia type 1. Medicine 1997; 76: 21-9.
10. Burgess JR, Shepherd J, Parameswaran V, Hoffman L, Greenaway T. Prolactinomas in a large men I kindred - clinical features and inheritance pattern. J Clin Endocrinol Metab 1996; 81: 1841-5.
11. Tisell L-E, Ahlman H. Treatment of the pancreatic disease of multiple endocrine neoplasia type 1. Acta Oncol 1989; 28: 415-7.
12. Farid NR, Buehler S, Russell NA, Maroun FB, Allerdice P. Prolactinomas in familial multiple endocrine neoplasia syndrome type 1: relationship to HLA and carcinoid tumours. Am J Med 1980; 69: 874-80.
13. Thakker R. The role of molecular genetics in screening for multiple endocrine neoplasia type 1. Endocrinol Metab Clin North Am 1994; 1: 117-35.
14. Shepherd JJ. Latent familial multiple endocrine neoplasia in Tasmania. Med J Aust 1985; 142: 395-7.
15. Burgess JR, Shepherd JJ, Parameswaran V, Hoffman L, Greenaway TM. The spectrum of pituitary disease in multiple endocrine neoplasia type I - the clinical, biochemical and radiological features of pituitary disease in a large MEN I kindred. J Clin Endocrinol Metab 1996; 81: 2642-6.
16. Burgess JR, Shepherd JJ, Parameswaran V, Hoffman L, Greenaway TM. Somatotrophinomas in multiple endocrine neoplasia type 1: a review of clinical phenotype and insulin-like growth factor-I levels in a large multiple endocrine neoplasia type I kindred. Am J Med 1996; 100: 544-7.
17. Burgess JR, Greenaway TM, Parameswaran V, Challis D, David R, Shepherd JJ. Enteropancreatic malignancy in MEN 1 - risk factors and pathogenesis. Cancer, in press.
18. Burgess JR, David R, Parameswaran V, Greenaway TM, Shepherd JJ. The outcome of subtotal parathyroidectomy for the treatment of hyperparathyroidism in Multiple Endocrine Neoplasia Type 1. Arch Surg 1998; 133: 126-9.
19. Wilkinson S, Teh B, Davey K et al. Cause of death in multiple endocrine neoplasia type 1. Arch Surg 1993; 128: 683-90.
20. Larsson C, Shepherd J, Nakamura Y et al. Predictive testing for multiple endocrine neoplasia type I using DNA polymorphisms. J Clin Invest 1992; 89: 1344-9.
21. Teh BT, McArdle J, Parameswaran V, David R, Larsson C, Shepherd JJ. Sporadic primary hyperparathyroidism in the setting of multiple endocrine neoplasia type 1. Arch Surg 1996; 131: 1230-32.
22. Shepherd J, Teh B, Parameswaran V, David R. Hyperparathyroidism with normal albumin corrected total calcium in patients with multiple endocrine neoplasia type 1. H Ford Hosp J 1992; 40: 186-90.